Ligand Pharmaceuticals Incorporated

NasdaqGM:LGND Stock Report

Mkt Cap: US$1.2b

Ligand Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:LGND Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Nov 22SellUS$128,283Octavio EspinozaIndividual1,696US$75.64
16 Sep 22SellUS$268,060John HigginsIndividual3,000US$90.00
13 May 22BuyUS$206,910Matthew FoehrIndividual2,500US$82.76

Insider Trading Volume

Insider Buying: LGND insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of LGND?
Owner TypeNumber of SharesOwnership Percentage
General Public792,1734.7%
Individual Insiders967,5245.7%
Institutions15,133,88289.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 76.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.51%
BlackRock, Inc.
2,789,479$199.3m4.65%no data
10.62%
The Vanguard Group, Inc.
1,793,414$128.1m1.1%no data
7.47%
Janus Henderson Group plc
1,262,333$90.2m-9.15%0.04%
5.63%
State Street Global Advisors, Inc.
951,318$68.0m-12.23%no data
4.7%
Macquarie Investment Management Business Trust
793,621$56.7m1.24%0.05%
2.86%
St. Denis J. Villere & Co., LLC
483,347$34.5m-1.58%2.37%
2.69%
Stephens Investment Management Group, LLC
454,416$32.5m0.59%0.51%
2.66%
Dimensional Fund Advisors LP
449,118$32.1m1.45%0.01%
2.62%
abrdn plc
442,359$31.6m3.21%0.02%
2.53%
William Blair Investment Management, LLC
427,306$30.5m5.17%0.05%
2.47%
John Higgins
417,695$29.8m14.07%no data
1.89%
Chicago Capital, LLC
319,054$22.8m-30.54%1.07%
1.72%
Geode Capital Management, LLC
290,110$20.7m-0.21%no data
1.69%
Rice Hall James & Associates, LLC
285,634$20.4m-3.72%0.98%
1.39%
Impax Asset Management Group plc
234,320$16.7m27.13%0.04%
1.07%
Invesco Capital Management LLC
180,409$12.9m-13.31%0.01%
1.02%
Northern Trust Global Investments
173,113$12.4m-12.22%no data
0.98%
Millennium Management LLC
166,217$11.9m109.31%0.01%
0.96%
Matthew Foehr
162,187$11.6m-11.13%no data
0.95%
Charles Schwab Investment Management, Inc.
160,577$11.5m0%no data
0.95%
BNY Mellon Asset Management
160,534$11.5m-1.26%no data
0.85%
Columbia Management Investment Advisers, LLC
144,013$10.3m-4.08%no data
0.75%
Medical Strategy GmbH, Asset Management Arm
126,087$9.0m3.47%0.54%
0.73%
Norges Bank Investment Management
122,571$8.8m0%no data
0.68%
Knott Partners Management, LLC
115,000$8.2m0%2.46%